Bio-Techne at World CB & CDx Summit | September 7-8, 2023 | Omni Boston Hotel at the Seaport | Boston, MA
Partnership from Discovery to Commercialization:
Bio-Techne delivers precision medicine solutions through validated assay development, a broad portfolio of quality protein analysis tools, multi-omics platforms with integrated bioinformatics, regulatory support, and more.
World CDx 2023
Building a foundation for successful companion diagnostics in an evolving international regulatory landscape
Bernard Andruss, Ph.D.
Vice President, Molecular Diagnostics Division
Bio-Techne
Thursday, September 7th | 9:40 AM ET
Fit-for-Purpose Assay Development and Validation Solutions
Fit-for-Purpose Assay Development and Validation Solutions
- Expertise supporting: PK/PD, target engagement, proof-of-mechanism, dose selection, patient stratification, primary and secondary endpoints, and other assays
- Multiple CLIA lab sites to support clinical testing needs
Broad Portfolio of High-Quality Protein Analysis Tools
Broad Portfolio of High-Quality Protein Analysis Tools
- Superior quality R&D Systems antibodies and immunoassays, as well as fully automated Protein Simple instrumentation platforms
- In-house technologies eliminate licensing barriers for streamlined commercialization
Integrated Multi-Omics Liquid Biopsy Platform
Integrated Multi-Omics Liquid Biopsy Platform
-
Leverage powerful bioinformatics and AI/ML capabilities for genomic, epigenomic, transcriptomic and proteomic analysis to support your biomarker strategy
Regulatory Support
Regulatory Support
-
Established track record of regulatory engagement (FDA and international regulatory bodies) to support a broad range of filings, from Pre-Submissions to 510(k) and PMA
